| 摘要 |
In a transdermal therapeutic system (TTS) comprising an impermeable backing layer, one or more matrix layers and a removable backing layer, the matrix layers contain active agent(s) (A) consisting of a dicarboxylic acid angiotensin converting enzyme (ACE) inhibitor which has been derivatized to give a diester, a di-salt with base(s) or a mono-salt with acid(s). In a transdermal therapeutic system (TTS) comprising an impermeable backing layer, one or more matrix layers (where at least one of the layers is self-adhesive or a separate adhesive layer is provided) and a removable backing layer, the matrix layers contain active agent(s) (A) consisting of a dicarboxylic acid angiotensin converting enzyme (ACE) inhibitor which has been derivatized to give a diester, a di-salt with base(s) or a mono-salt with acid(s). |
